These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22114850)

  • 1. Duration of drug interactions: putative time courses after mechanism-based inhibition or induction of CYPs.
    Imai H; Kotegawa T; Ohashi K
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):409-11. PubMed ID: 22114850
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism-based drug-drug interactions: what determines individual variability in cytochrome P450 induction?
    Tang C; Lin JH; Lu AY
    Drug Metab Dispos; 2005 May; 33(5):603-13. PubMed ID: 15673596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual variability in inhibition and induction of cytochrome P450 enzymes.
    Lin JH; Lu AY
    Annu Rev Pharmacol Toxicol; 2001; 41():535-67. PubMed ID: 11264468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions with cytochrome P-450.
    Mege J
    Pa Med; 1998 Sep; 101(9):16-7. PubMed ID: 9782709
    [No Abstract]   [Full Text] [Related]  

  • 6. Updates on cytochrome P450-mediated cardiovascular drug interactions.
    Cheng JW; Frishman WH; Aronow WS
    Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of CYP-mediated drug interactions in vivo using in vitro data.
    Foti RS; Wahlstrom JL
    IDrugs; 2008 Dec; 11(12):900-5. PubMed ID: 19051152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytochrome P-450: the effect of drugs and poisons].
    Chekman IS; Grinevich AI
    Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
    [No Abstract]   [Full Text] [Related]  

  • 9. The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.
    Bjornsson TD; Callaghan JT; Einolf HJ; Fischer V; Gan L; Grimm S; Kao J; King SP; Miwa G; Ni L; Kumar G; McLeod J; Obach SR; Roberts S; Roe A; Shah A; Snikeris F; Sullivan JT; Tweedie D; Vega JM; Walsh J; Wrighton SA;
    J Clin Pharmacol; 2003 May; 43(5):443-69. PubMed ID: 12751267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A basic conceptual and practical overview of interactions with highly prescribed drugs.
    Dresser GK; Bailey DG
    Can J Clin Pharmacol; 2002; 9(4):191-8. PubMed ID: 12584577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of the inhibition of cytochrome P-450-mediated drug oxidation by therapeutic agents.
    Murray M
    Drug Metab Rev; 1987; 18(1):55-81. PubMed ID: 3311684
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinico-pharmacological aspects of enzyme induction].
    Bartłomowicz B
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1430-3. PubMed ID: 3913943
    [No Abstract]   [Full Text] [Related]  

  • 13. [The induction of microsomal cytochrome P-450 and its medical consequences].
    Pfeil D; Friedrich J
    Pharmazie; 1985 Apr; 40(4):217-21. PubMed ID: 3892550
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.
    Masubuchi Y; Horie T
    Crit Rev Toxicol; 2007 Jun; 37(5):389-412. PubMed ID: 17612953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
    Murray M
    Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the effect of drugs due to reciprocal interference with their protein binding and catabolism].
    Remmer H
    Dtsch Med Wochenschr; 1974 Mar; 99(9):413-9. PubMed ID: 4857236
    [No Abstract]   [Full Text] [Related]  

  • 17. Human CYPs: in vivo and clinical aspects.
    Pelkonen O
    Drug Metab Rev; 2002; 34(1-2):37-46. PubMed ID: 11996010
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytochrome P450 metabolism and inhibition: analysis for drug discovery.
    Jones BC; Middleton DS; Youdim K
    Prog Med Chem; 2009; 47():239-63. PubMed ID: 19328293
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Drug metabolism in the human liver measured with in vitro and in vivo methods.
    Remmer H
    Arzneimittelforschung; 1976; 26(6):1262-3. PubMed ID: 989459
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatic mono-oxygenases].
    Robillart A; Zeisser M; Vailly B; Dupeyron JP
    Ann Fr Anesth Reanim; 1988; 7(2):149-55. PubMed ID: 3364813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.